- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2011
- Public Summary Document (PSD) March 2011 PBAC Meeting - PDF
Lenalidomide – March 2011
Lenalidomide, capsules, 5 mg and 10 mg, Revlimid® - March 2011
Last updated
15 July 2011